Results per Page:
‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies
Dr. Folashade Otegbeye is the recipient of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
RNA “typos” can highlight leukemia cells for immune attack
Looking beyond DNA, scientists find possible “surgically targeted” option for splicing factor-mutant blood cancers that lack effective immunotherapies
Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology
In-house grant funding program will underpin efforts to advance therapies to clinical trials
Endocrine Tumor Program at Fred Hutch launches survivorship clinic
New clinic provides long-term care for thyroid tumors and endocrine immune-related adverse events
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia